IMVT
Immunovant, Inc. · Healthcare
Chief Financial Officer Tiago Girao sold $263K of Immunovant, Inc.
Sold$263,015
$38.69Price
6,798Shares
−3%Stake
What IMVT did after the filing
- The stock from Mon, Jul 27 open, $39.97
- −3.1%
- S&P 500, same days
- +2.3%
Measured over 30 trading days, to the Sep 9 close.
Traded Thu, Jul 23. Filed Fri, Jul 24, 5:57 PM ET, after the close. Returns use the Jul 27 open and the Sep 9 close. Not investment advice.